Anika Therapeutics, Inc. SEC filings ANIK

Anika Therapeutics, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Dec 19, 2003. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 29, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Anika Therapeutics, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jul 29, 2026 —
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
8-K Current report
Material agreement, New debt
Jul 14, 2026 Jul 10, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 23, 2026 Jun 18, 2026
DEFA14A Additional proxy material Jun 8, 2026 —
DEFA14A Additional proxy material Jun 1, 2026 —
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations, Officer or director change
Apr 29, 2026 Apr 24, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 18, 2026
10-K Annual report Mar 3, 2026 Dec 31, 2025
8-K Current report
Results of operations, Officer or director change
Feb 26, 2026 Feb 26, 2026
8-K Current report
Results of operations, Officer or director change
Jan 8, 2026 Jan 7, 2026
S-8 Employee stock plan registration Nov 5, 2025 —
10-Q Quarterly report Nov 5, 2025 Sep 30, 2025
8-K Current report
Results of operations, Other events
Nov 5, 2025 Nov 5, 2025
10-Q Quarterly report Jul 30, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 30, 2025 Jul 30, 2025
8-K Current report
Regulation FD disclosure
Jul 30, 2025 Jul 30, 2025
UPLOAD Letter from the SEC Jul 24, 2025 —
CORRESP Letter to the SEC Jul 17, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 24, 2025 Jun 20, 2025
UPLOAD Letter from the SEC Jun 18, 2025 —
10-Q Quarterly report May 9, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 9, 2025 May 9, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 20, 2025
8-K Current report
Officer or director change
Apr 10, 2025 Apr 4, 2025
10-K Annual report Mar 17, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 12, 2025 Mar 12, 2025
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Mar 11, 2025 Mar 7, 2025
10-Q Quarterly report Nov 4, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
Oct 31, 2024 Oct 31, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
8-K Current report
Shareholder vote results
Jul 11, 2024 Jul 9, 2024
DEFA14A Additional proxy material Jun 25, 2024 —
ARS Annual report to shareholders Jun 11, 2024 Dec 31, 2023
DEF 14A Proxy statement Jun 11, 2024 Jul 9, 2024
S-8 Employee stock plan registration May 31, 2024 —
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
May 28, 2024 May 28, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Officer or director change
May 8, 2024 May 2, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
10-K/A Amended annual report Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 15, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 13, 2024 Mar 13, 2024
8-K Current report
Officer or director change
Feb 26, 2024 Feb 24, 2024
S-8 POS Filing Jan 22, 2024 —
S-8 Employee stock plan registration Jan 19, 2024 —
10-Q Quarterly report Nov 3, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Regulation FD disclosure
Sep 21, 2023 Sep 21, 2023
S-8 Employee stock plan registration Aug 8, 2023 —
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 21, 2023 Jun 14, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
ARS Annual report to shareholders May 1, 2023 Dec 31, 2022
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 —
8-K Current report
Other events
Apr 28, 2023 Apr 24, 2023
PRER14A Filing Apr 25, 2023 —
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Apr 13, 2023 Apr 13, 2023
PRRN14A Anika therapeutics, inc. Apr 6, 2023 —
UPLOAD Letter from the SEC Apr 5, 2023 —
CORRESP Letter to the SEC Apr 5, 2023 —
PRER14A Filing Apr 5, 2023 —
UPLOAD Letter from the SEC Apr 4, 2023 —
PREC14A Anika therapeutics, inc. Mar 30, 2023 —
DEFA14A Additional proxy material Mar 27, 2023 —
PREC14A Filing Mar 27, 2023 —
10-K Annual report Mar 16, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 6, 2023 Mar 6, 2023
DFAN14A Anika therapeutics, inc. Feb 21, 2023 —
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Other events
Nov 1, 2022 Nov 1, 2022
S-8 Employee stock plan registration Aug 5, 2022 —
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 3, 2022 Aug 3, 2022
8-K Current report
Officer or director change, Shareholder vote results
Jun 10, 2022 Jun 8, 2022
DEFA14A Additional proxy material Jun 3, 2022 —
DEFA14A Additional proxy material Jun 1, 2022 —
DEFR14A Filing Jun 1, 2022 —
DEFA14A Additional proxy material May 9, 2022 —
10-Q Quarterly report May 6, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEF 14A Proxy statement Apr 27, 2022 Jun 8, 2022
DEFA14A Additional proxy material Apr 27, 2022 —
10-K Annual report Mar 11, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 8, 2022 Mar 8, 2022
8-K Current report
Material agreement, New debt
Nov 15, 2021 Nov 12, 2021
S-8 Employee stock plan registration Nov 5, 2021 —
10-Q Quarterly report Nov 5, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Nov 1, 2021 Oct 28, 2021
S-8 Employee stock plan registration Aug 6, 2021 —
S-8 Employee stock plan registration Aug 6, 2021 —
10-Q Quarterly report Aug 6, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Other events
Jun 30, 2021 Jun 24, 2021
8-K Current report
Officer or director change, Shareholder vote results
Jun 22, 2021 Jun 16, 2021
10-Q Quarterly report May 7, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
DEFA14A Additional proxy material Apr 30, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 16, 2021
10-K/A Amended annual report Apr 26, 2021 Dec 31, 2020
10-K Annual report Mar 5, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 4, 2021 Mar 4, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 4, 2020 Nov 4, 2020
8-K Current report
Other events
Oct 21, 2020 Oct 21, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 8, 2020 Sep 3, 2020
10-Q Quarterly report Aug 7, 2020 Jun 30, 2020
10-Q/A Amended quarterly report Aug 6, 2020 Mar 31, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 5, 2020 Aug 5, 2020
8-K Current report
Results of operations
Jul 30, 2020 Jul 30, 2020
S-8 Employee stock plan registration Jun 19, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2020 Jun 16, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 2, 2020 May 27, 2020
10-Q Quarterly report May 22, 2020 Mar 31, 2020
8-K Current report
Other events
May 8, 2020 May 7, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
8-K Current report
Material agreement, Officer or director change, Regulation FD disclosure
Apr 29, 2020 Apr 23, 2020
DEFA14A Additional proxy material Apr 29, 2020 —
DEF 14A Proxy statement Apr 29, 2020 Jun 16, 2020
8-K Current report
New debt
Apr 8, 2020 Apr 8, 2020
8-K/A Amended current report Mar 13, 2020 Feb 3, 2020
8-K/A Amended current report Mar 13, 2020 Jan 24, 2020
10-K Annual report Mar 6, 2020 Dec 31, 2019
8-K Current report
Officer or director change
Mar 2, 2020 Feb 25, 2020
8-K Current report
Results of operations
Feb 20, 2020 Feb 20, 2020
SEC STAFF LETTER Filing Feb 19, 2020 —
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 14, 2020 Feb 10, 2020
8-K Current report
Acquisition or sale of assets, Other events
Feb 3, 2020 Feb 3, 2020
SEC STAFF LETTER Filing Jan 31, 2020 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 30, 2020 Jan 29, 2020
8-K Current report
Acquisition or sale of assets, Other events
Jan 24, 2020 Jan 24, 2020
8-K Current report
Material agreement
Jan 7, 2020 Jan 4, 2020
8-K Current report
Other events
Jan 6, 2020 Jan 6, 2020
10-Q Quarterly report Oct 28, 2019 Sep 30, 2019
8-K Current report
Results of operations
Oct 25, 2019 Oct 24, 2019
10-Q Quarterly report Jul 26, 2019 Jun 30, 2019
8-K Current report
Results of operations
Jul 24, 2019 Jul 24, 2019
8-K Current report
Officer or director change
Jul 10, 2019 Jul 5, 2019
8-K Current report
Officer or director change
Jun 26, 2019 Jun 20, 2019
S-8 Employee stock plan registration Jun 21, 2019 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 20, 2019 Jun 18, 2019
8-K Current report
Material agreement, Other events
May 13, 2019 May 2, 2019
10-Q Quarterly report May 6, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 2, 2019 May 2, 2019
DEFA14A Additional proxy material Apr 25, 2019 —
DEF 14A Proxy statement Apr 25, 2019 Jun 18, 2019
8-K Current report
Officer or director change
Apr 12, 2019 Apr 9, 2019
8-K Current report
Officer or director change
Mar 26, 2019 Mar 25, 2019
10-K Annual report Feb 27, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 21, 2019 Feb 21, 2019
10-Q Quarterly report Oct 26, 2018 Sep 30, 2018
8-K Current report
Results of operations
Oct 24, 2018 Oct 24, 2018
8-K Current report
Officer or director change
Oct 24, 2018 Oct 23, 2018
8-K Current report
Officer or director change
Sep 5, 2018 Aug 31, 2018
10-Q Quarterly report Jul 31, 2018 Jun 30, 2018
8-K Current report
Results of operations
Jul 25, 2018 Jul 25, 2018
8-K Current report
Other events
Jun 19, 2018 Jun 19, 2018
8-K Current report
Shareholder vote results, Other events
Jun 6, 2018 May 31, 2018
8-K Current report
Material agreement
May 29, 2018 May 24, 2018
10-Q Quarterly report May 10, 2018 Mar 31, 2018
8-K Current report
Results of operations
May 2, 2018 May 2, 2018
DEFA14A Additional proxy material Apr 17, 2018 —
DEF 14A Proxy statement Apr 17, 2018 May 31, 2018
PRE 14A Preliminary proxy statement Apr 6, 2018 May 31, 2018
8-K Current report
Officer or director change, Other events
Mar 8, 2018 Mar 2, 2018
10-K Annual report Feb 27, 2018 Dec 31, 2017
8-K Current report
Results of operations
Feb 21, 2018 Feb 21, 2018
8-K Current report
Officer or director change
Jan 2, 2018 Dec 27, 2017
10-Q Quarterly report Oct 27, 2017 Sep 30, 2017
8-K Current report
Results of operations
Oct 25, 2017 Oct 25, 2017
10-Q Quarterly report Jul 28, 2017 Jun 30, 2017
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 27, 2017 Jul 27, 2017
8-K Current report
Results of operations
Jul 26, 2017 Jul 26, 2017
8-K Current report
Officer or director change
Jul 14, 2017 Jul 10, 2017
S-8 Employee stock plan registration Jul 7, 2017 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 19, 2017 Jun 13, 2017
8-K/A Amended current report
Auditor change
May 5, 2017 Apr 24, 2017
10-Q Quarterly report May 4, 2017 Mar 31, 2017
8-K Current report
Results of operations
May 3, 2017 May 3, 2017
DEFA14A Additional proxy material Apr 28, 2017 —
DEF 14A Proxy statement Apr 28, 2017 Jun 13, 2017
8-K Current report
Auditor change
Apr 28, 2017 Apr 24, 2017
10-K Annual report Feb 24, 2017 Dec 31, 2016
8-K Current report
Results of operations
Feb 15, 2017 Feb 15, 2017
8-K Current report
Material agreement
Feb 8, 2017 Feb 2, 2017
8-K Current report
Officer or director change
Jan 27, 2017 Jan 23, 2017
8-K Current report
Agreement ended
Jan 9, 2017 Dec 29, 2016

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
ANIK (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Bedford, MA
SEC filer status
Accelerated filer
SEC CIK
898437
Former names
ANIKA THERAPEUTICS INC (until Mar 13, 2014); ANIKA RESEARCH INC (until Nov 27, 1996)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.